CureVac N.V. (5CV.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 07:29PM CEST. Market open.
| Previous Close | 3.0040 |
| Open | 3.0800 |
| Bid | 2.8780 x N/A |
| Ask | 2.9100 x N/A |
| Day's Range | 2.8780 - 3.0800 |
| 52 Week Range | 2.0560 - 9.6000 |
| Volume | |
| Avg. Volume | 35,358 |
| Market Cap | 663.558M |
| Beta (5Y Monthly) | 2.64 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued
Key Insights The projected fair value for CureVac is US$5.84 based on 2 Stage Free Cash Flow to Equity CureVac is...
- Zacks
GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
GSK revamps its existing collaboration deal with partner CureVac, converting it from a collaboration deal into a licensing agreement related to mRNA vaccine candidates for COVID-19 and influenza.
- Zacks
Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
GSK and CureVac (CVAC) are in the spotlight following a restructuring of their vaccine agreement.
© 2024 Yahoo. All rights reserved.